Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

Published

Journal Article

BACKGROUND: Autosomal dominant hyper-IgE syndrome (AD-HIES) is a rare condition. OBJECTIVE: Data from the USIDNET Registry provide a resource to examine the characteristics of patients with rare immune deficiency diseases. METHODS: A query was submitted to the USIDNET requesting deidentified data for patients with physician-diagnosed AD-HIES through July 2016. RESULTS: Data on 85 patients diagnosed with AD-HIES (50 males; 35 females) born between 1950 and 2013, collected by 14 physicians from 25 states and Quebec, were entered into the USIDNET Registry by July 2016. Cumulative follow-up was 2157 years. Of these patients, 45.9% had a family history of HIES. The complications reported included skin abscesses (74.4%), eczema (57.7%), retained primary teeth (41.4%), fractures (39%), scoliosis (34.1%), and cancer (7%). Reported allergic diseases included food (37.8%), environmental (18%), and drugs (42.7%). The mean serum IgE level was 8383.7 kU/mL and was inversely correlated to the patient's age. A total of 49.4% had eosinophilia; 56% were known to be on trimethoprim-sulfamethoxazole, 26.6% on antifungal coverage, and 30.6% on immunoglobulin replacement therapy. Pneumonias were more commonly attributed to Staphylococcus aureus (55.3%) or Aspergillus fumigatus (22.4%); 19.5% had a history of lung abscess; these were most often associated with Pseudomonas aeruginosa (P Fisher's exact test = .029) or A. fumigatus (P Fisher's exact test = .016). Lung abscesses were significantly associated with drug reactions (P χ2 = .01; odds ratio: 4.03 [1.2-12.97]), depression (P Fisher's exact test = .036), and lower Karnofsky index scores (P Mann-Whitney = .007). DISCUSSION: Data from the USIDNET Registry summarize the currently reported clinical characteristics of a large cohort of subjects with AD-HIES.

Full Text

Duke Authors

Cited Authors

  • Gernez, Y; Freeman, AF; Holland, SM; Garabedian, E; Patel, NC; Puck, JM; Sullivan, KE; Akhter, J; Secord, E; Chen, K; Buckley, R; Haddad, E; Ochs, HD; Fuleihan, R; Routes, J; Muskat, M; Lugar, P; Mancini, J; Cunningham-Rundles, C

Published Date

  • May 2018

Published In

Volume / Issue

  • 6 / 3

Start / End Page

  • 996 - 1001

PubMed ID

  • 28939137

Pubmed Central ID

  • 28939137

Electronic International Standard Serial Number (EISSN)

  • 2213-2201

Digital Object Identifier (DOI)

  • 10.1016/j.jaip.2017.06.041

Language

  • eng

Conference Location

  • United States